SCHEMBL19510596

SCHEMBL19510596

FC(F)(CBr)c1ccc(Br)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
CYP2A6 P11509 1/20 0.40
GSK3B P49841 2/20 0.33
TRPV1 Q8NER1 1/20 0.33
PTPN1 P18031 1/20 0.33
OGG1 O15527 1/20 0.32
ALDH1A1 P00352 2/20 0.32
ALOX15 P16050 2/20 0.32
MAPK1 P28482 1/20 0.32
HTR2A P28223 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
SLC6A4 P31645 1/20 0.30
PLCG1 P19174 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4785402 0.80 KCNN4 (0.37) CA1CA2CA9GSK3BPTPN1
SCHEMBL15974610 0.80 CA1 (0.43) CA1CA2CA5ACA9CYP2A6
SCHEMBL11579 0.78 CA1 (0.42) CA1CA2CA5ACA9CYP2A6
SCHEMBL9063945 0.78 CA1 (0.42) CA1CA2CA5ACA9CYP2A6
SCHEMBL17723819 0.78 CA1 (0.47) CA1CA2CA5ACA9CYP2A6
SCHEMBL4701959 0.78 CYP19A1 (0.41) CYP2A6GSK3BMAPK1
SCHEMBL11922 0.78 CA1 (0.42) CA1CA2CA5ACA9CYP2A6
SCHEMBL2281974 0.77 TSHR (0.50) CA1CA2CA5ACA9PTPN1
SCHEMBL23616397 0.76 CA1 (0.41) CA1CA2CA5ACA9CYP2A6
SCHEMBL12807003 0.76 CA1 (0.41) CA1CA2CA5ACA9CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567443-B Biaryl derivatives as GPR120 agonists 株式会社LG化学 2023-04-28 CN disclosed
CN-115925679-A Biaryl derivatives as GPR120 agonists 株式会社LG化学 2023-04-07 CN disclosed
EP-3239143-B1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEMICAL LTD (KR) 2023-03-22 EP disclosed
US-20220135574-A1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEM, LTD. (KR) 2022-05-05 US disclosed
US-11261186-B2 Biaryl derivative as GPR120 agonist LG CHEM. LTD. (KR) 2022-03-01 US disclosed
US-20170349594-A1 BIARYL DERIVATIVE AS GPR120 AGONIST LG CHEM, LTD. (KR) 2017-12-07 US disclosed
EP-3239143-A2 BIARYL DERIVATIVE AS GPR120 AGONIST LG Chem, Ltd. (KR) 2017-11-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135574-A1 BIARYL DERIVATIVE AS GPR120 AGONIST GPR119, GLP1R, GIPR CA1 4658/4885CA2 3561/4885CA5A 2566/4885
US-20170349594-A1 BIARYL DERIVATIVE AS GPR120 AGONIST GPR119, GLP1R, GIPR CA1 4658/4885CA2 3561/4885CA5A 2566/4885
US-11261186-B2 Biaryl derivative as GPR120 agonist GPR119, GPR88, FFAR1 CA1 4805/4885CA2 3875/4885CA5A 3090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.